Dow Jones

39,118.86

-0.12%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Innate Pharma (PK) (IPHYF)
Innate Pharma (PK) (IPHYF) News

Innate Pharma (PK) (IPHYF)

Innate Pharma (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IPHYF

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
18/06/2024	12:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
17/06/2024	11:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
14/05/2024	11:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
07/05/2024	11:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/03/2024	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/03/2024	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
21/02/2024	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/02/2024	22:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/02/2024	22:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:IPHYF	Innate Pharma (PK)
19/12/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
18/12/2023	16:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/12/2023	11:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
11/12/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
27/11/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
07/11/2023	11:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
16/10/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
05/10/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
22/09/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
10/08/2023	11:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
26/06/2023	11:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
12/06/2023	11:45	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
12/06/2023	11:44	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
08/06/2023	11:02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
07/06/2023	11:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
26/05/2023	11:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
15/05/2023	11:28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
12/05/2023	21:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
10/05/2023	11:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
09/05/2023	11:05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
26/04/2023	21:04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)